Healthpeak Properties
NYSE: DOC
Stock price
18.52 USD
(+0%) TODAY
Add to comparison table
Financials
all figures in US$ Millions except per share data
Sections:
Periods:
View:
Format:
Actual
10 year cagr
Where available up to 10y CAGR shown for absolute numbers
10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Earnings per share = Net Income / Number of Shares Outstanding
(1.2)
1.3
0.9
2.2
0.1
0.8
0.9
0.9
0.6
0.4
0.1
-
02Free cash flow per share
2.6
2.6
1.8
1.8
1.7
1.4
1.5
1.7
1.7
1.6
1.8
(3.8)%
03Dividends per share
2.1
2.4
2.2
2.4
2.4
2.4
2.1
2.1
2.1
1.4
1.2
(5.1)%
04Dividends payout, %
(1.9)%
1.6%
1.7%
65.7%
15.8%
1.9%
1.3%
1.3%
2.2%
3.3%
11.9%
-
PROFIT AND LOSS STATEMENT
05Revenue
1,941
2,129
1,848
1,191
1,240
1,645
1,896
2,061
2,181
2,700
2,823
3.8%
06% Change
-
-
-
-
-
-
-
-
-
-
-
3.8%
07Cost of revenue
(610.7)
(738.4)
(666.3)
(378.7)
(405.2)
(782.5)
(773.3)
(863)
(902.1)
(1,075)
(2,188)
13.6%
08Gross profit
1,330
1,391
1,182
812.7
835.1
862.3
1,123
1,198
1,279
1,626
634.5
(7.1)%
09% Margin
68.5%
65.3%
64%
68.2%
67.3%
52.4%
59.2%
58.1%
58.6%
60.2%
22.5%
58.6% A
10Operating expenses
(600.9)
(671.7)
(623.5)
(501.4)
(528.2)
(647.2)
(782.6)
(841.6)
(845)
(1,154)
(90.4)
(17.3)%
11% of Revenue
(31)%
(31.6)%
(33.7)%
(42.1)%
(42.6)%
(39.4)%
(41.3)%
(40.8)%
(38.8)%
(42.8)%
(3.2)%
(35.2)% A
12Operating Income
728.9
719.2
558.6
311.3
306.9
215.1
340.3
356.6
433.9
471.2
544.1
(2.9)%
13Income tax expense
(9.8)
(4.5)
(1.3)
(4.4)
(5.5)
(9.4)
(3.3)
(4.4)
(9.6)
(4.3)
(9.3)
-
14Net Income
(559.2)
627.7
414.2
1,061
45.5
413.6
505.5
500.4
306
243.1
71.3
-
15% Margin
(28.8)%
29.5%
22.4%
89.1%
3.7%
25.1%
26.7%
24.3%
14%
9%
2.5%
19.8% A
16Shares Outstanding
462.8
467.4
468.9
475.4
489.3
531.1
539.2
539.1
547.3
676.2
696
4.2%
17EPS Basic
(1.2)
1.3
0.9
2.3
0.1
0.8
0.9
0.9
0.6
0.4
0.1
-
18EPS Diluted
(1.2)
1.3
0.9
2.2
0.1
0.8
0.9
0.9
0.6
0.4
0.1
-
19EBITDA
1,121
1,400
1,253
1,649
1,054
1,133
970.6
1,391
1,265
1,611
1,474
2.8%
% Margin
57.8%
65.7%
67.8%
138.5%
85%
68.9%
51.2%
67.5%
58%
59.7%
52.2%
70.2% A
20Net Interest Income (expense)
(367.4)
(375.6)
(251.5)
(250.9)
(207.8)
(218.3)
(158)
(172.9)
(200.3)
(280.4)
(305.2)
(1.8)%
21Net Debt / EBITDA
0.4
0.7
1.2
0.9
5.8
5.7
6.4
4.8
5.5
5.5
6.7
4 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
3.1
15.5
2.7
19.2
80.4
44.2
158.3
72
117.6
119.8
537.7
67.2%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
1,185
853.1
354.1
111.2
235.4
237.6
464.5
428.3
274.3
794
684.3
(5.3)%
25Other current assets
5,700
970.1
443.9
137.1
3,662
2,694
90.6
104.7
169.4
72.3
(148.6)
-
26Inventory
-
(14.8)
(22.9)
(21.6)
-
-
-
-
-
-
-
20.8%
27Total Current Assets
92.7
64.4
88.9
83.7
3,978
2,975
713.4
605
561.3
986.1
1,074
27.8%
Non-Current Assets
28Net property, plant & equipment
11,854
11,326
10,732
10,210
167.3
192.3
233.9
237.3
240.2
424.2
412.2
(28.5)%
29Long-term investments
1.3
2.3
1.3
1.3
859
447.6
448.3
706.7
782.9
936.8
802.6
89.8%
30Other non-current assets
(10,303)
(8,504)
(6,658)
(6,152)
9,029
12,305
13,862
14,222
14,115
17,591
31.7
-
31Total Non-Current Assets
1,552
2,824
4,076
4,059
10,055
12,945
14,544
15,166
15,138
18,952
1,247
(2.2)%
Total Assets
1,645
2,888
4,164
4,143
14,033
15,920
15,258
15,771
15,699
19,938
20,336
28.6%
LIABILITIES
Current Liabilities
32Accounts payable
0.6
-
-
-
457.5
269.1
227.6
265.6
240.3
276
718.5
101.7%
33Short-term debt
-
92.4
3.5
3.6
93
129.6
1,166
995.6
720
171.5
-
8%
34Other current liabilities
422.7
630.2
432.1
577.8
403.7
907.2
542.8
511
417.7
427.9
266.8
(4.5)%
35Total Current Liabilities
423.4
722.6
435.6
581.4
954.2
1,306
1,936
1,772
1,378
875.3
985.3
8.8%
Non-Current Liabilities
36Long-term debt
11,125
8,349
7,930
5,564
6,062
6,348
5,209
5,711
6,363
8,852
10,440
(0.6)%
37Other non-current liabilities
(11,007)
(7,992)
(6,761)
(4,475)
349.5
918.5
966.4
1,000
1,033
1,154
607.8
-
38Total Non-Current Liabilities
118.1
356.7
1,169
1,089
6,411
7,267
6,175
6,711
7,396
10,005
11,048
57.4%
39Total Liabilities
541.5
1,079
1,604
1,670
7,365
8,573
8,111
8,483
8,774
10,881
12,034
36.4%
SHAREHOLDERS` EQUITY
40Common stock
0.9
1.4
1.8
1.8
505.2
538.4
539.1
546.6
547.2
699.5
695
95.1%
41Retained earnings / (deficit)
(109)
(197.3)
(315.4)
(428.3)
(3,601)
(3,976)
(4,121)
(4,270)
-
(5,174)
(5,953)
49.2%
42Accumulated other comprehensive income / (loss)
(2,769)
13.7
14
14.4
(2.9)
(3.7)
(3.1)
28.1
19.4
28.8
(9.9)
(43.1)%
43Noncontrolling interests
82.3
70.3
86.8
92.9
582.4
613.6
630.6
633.6
574.4
656.3
802.4
25.6%
44Total shareholders' equity
1,103
1,809
2,560
2,472
6,668
7,347
7,146
7,288
6,925
9,058
8,303
22.4%
45Total Liabilities and shareholders' Equity
1,645
2,888
4,164
4,143
14,033
15,920
15,258
15,771
15,699
19,938
20,336
28.6%
46Total Debt
489.6
991.2
1,478
1,533
6,155
6,478
6,375
6,706
7,083
9,023
10,440
35.8%
47Net Debt
486.5
975.7
1,475
1,514
6,074
6,434
6,216
6,634
6,965
8,904
9,903
35.2%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
(559.2)
627.7
414.2
1,061
45.5
413.6
505.5
500.4
306
243.1
71.3
-
49Depreciation & amortization
504.9
568.1
534.7
549.5
660
697.1
684.3
710.6
749.9
1,057
1,022
7.3%
50Share-based compensation expense
26.1
22.9
14.3
16.6
18.2
17.4
18.2
26.5
14.5
31.8
14.4
(5.8)%
51Changes in working capital and other assets
1,250
(4.6)
(116.1)
(778.4)
122.4
(369.6)
(412.8)
(337.2)
(114.1)
(261.6)
144.1
(19.4)%
52Net cash flows from operating activities
1,222
1,214
847
848.7
846.1
758.4
795.2
900.3
956.2
1,071
1,252
0.2%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
-
-
-
-
-
-
-
-
-
-
-
-
54Purchases of investments / marketable securities
-
(73.3)
-
-
-
(394.2)
-
-
-
-
-
52.3%
55Proceeds from maturities of marketable securities
628
232
558.8
148
274.2
202.8
-
-
-
-
-
(20.2)%
56Other investing activities
(2,288)
(587.7)
687.5
1,681
(1,723)
(816.3)
531
(876.3)
(576.8)
(113.8)
(1,035)
(7.6)%
57Net cash flows from investing activities
(1,660)
(429)
1,246
1,829
(1,449)
(1,008)
531
(876.3)
(576.8)
(113.8)
(1,035)
(4.6)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
197.7
59
23.3
214.2
790.5
1,058
(7.8)
240.3
(6.2)
(190.4)
(96)
-
59Dividends paid, net
(1,047)
(979.5)
(695)
(696.9)
(720.1)
(787.1)
(650.1)
(648)
(657)
(794.8)
(849.1)
(2.1)%
60Debt issuance (repayments), net
1,378
(66.5)
(1,463)
(1,380)
653.7
63
(301)
324.6
378.1
153.2
1,109
(2.2)%
61Other financing activities
84.6
(67.1)
(13.8)
(757.4)
(76.8)
(87.8)
(329.6)
(33.3)
(52.1)
(109.5)
(27.5)
-
62Net cash flows from financing activities
614.1
(1,054)
(2,149)
(2,621)
647.3
246.5
(1,289)
(116.5)
(337.3)
(941.4)
136.1
(14)%
63Increase (decrease) in cash and cash equivalents
168.3
(270.1)
(54.8)
57.6
44.8
(3)
37.8
(92.6)
42.2
15.3
353.4
7.7%
64Cash and equivalents, ending balance
401.1
137
82.2
61.1
184.7
181.7
219.4
126.8
169
184.3
537.7
3%
65Free Cash Flow to the Firm (FCFF)
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
1,222
1,214
847
848.7
846.1
758.4
795.2
900.3
956.2
1,071
1,252
0.2%
Annual Reports, Presentations And IR Contacts
Go to the websiteHealthpeak Properties (DOC) financial statements and performance
Explore Healthpeak Properties (DOC) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.
Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.